Halifax Health And Government Settle False Claims Act Claims For $85 Million, But Case Is Not Over

by Akerman LLP - Health Law Rx
Contact

On March 10, 2014, Halifax Hospital Medical Center and Halifax Staffing, Inc. (collectively, "Halifax") entered into a settlement agreement and a corporate integrity agreement ("CIA") to resolve claims brought under the False Claims Act ("FCA"), alleging Halifax entered into improper incentive compensation arrangements with certain physicians in exchange for Medicare referrals. Halifax agreed to, among other things, pay $85 million in damages, with nearly a quarter of the settlement to go to the qui tam relator, and admit that it violated the Stark Law as described in an earlier ruling by the court. The settlement is said to be one of the largest for Stark Law violations.

Under the CIA, which has a five-year term, Halifax must retain an Independent Review Organization ("IRO") to perform annual reviews for submission to the OIG on whether Halifax is complying with the terms of its CIA. The CIA also requires the Board of Commissioners of Halifax to be responsible for the review and oversight of matters related to compliance with Federal health program requirements and the obligations of the CIA, including meeting at least bimonthly to review and oversee the compliance program and considering the results of the compliance program reviews required by the CIA. In addition to the IRO, Halifax must retain a "Board compliance expert" to assist the Board of Commissioners in fulfilling these responsibilities during the term of the CIA. The CIA also includes the standard reporting and certification requirements found in these types of agreements. The settlement and corresponding CIA arises out of a June 2009 lawsuit filed by qui tam relator, Elin Baklid-Kunz, the Director of Physician Services at Halifax. Relator's lawsuit alleged improper billing practices and unnecessary medical admissions in violation of the FCA, and separate Stark Law violations based on alleged improper incentive compensation arrangements whereby physician bonus payments were divided and varied based on the volume of Medicare referrals by each physician. This, in turn, led Halifax to falsely certify compliance with the Stark Law and submit claims in violation of the FCA.

In October 2011, the Government intervened as to the Stark Law-related claims, but declined to intervene as to relator's remaining FCA claims alleging improper billing practices and unnecessary medical admissions. In November 2013, the Court granted partial summary judgment for the Government, finding a Stark Law violation in fact occurred due to the incentive compensation arrangement, but found a genuine dispute of fact regarding the extent of the violation and whether Halifax acted "knowingly" as required to state a claim under the FCA. The Court also did not address relator's remaining FCA claims and thereafter severed, for purposes of trial, the "knowledge" and damages elements of the alleged Stark Law violations from relator's remaining FCA claims alleging improper billing practices and unnecessary medical admissions.

The March 10, 2014 settlement resolves only the alleged Stark Law violations. The remaining FCA violations advanced by relator for improper billing practices and unnecessary medical admissions are set for trial on July 8, 2014.  

Though beyond the scope of this discussion, the Halifax case also dealt with the attorney client privilege and whether such privilege had been waived by Halifax by virtue of the manner in which the internal investigation had been handled. As a result, practitioners should carefully review the court's analysis of this issue.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Akerman LLP - Health Law Rx | Attorney Advertising

Written by:

Akerman LLP - Health Law Rx
Contact
more
less

Akerman LLP - Health Law Rx on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.